Dr Aili Zhu is a graduate of the Heilongjiang University of Chinese Medicine. Her background is in both western pharmaceutical medicine and Chinese traditional medicines. Aili joined the CUK team upon hearing the ambition of the company, leaving her previous post of ten years managing a research and development pharmaceuticals facility.
In her previous role Aili was responsible for negotiating with Government officials in China for the approval of new medicines to the market. Additionally she dealt with University R&D departments and international private sector companies. Aili comes with a wealth of knowledge and contacts from the health, education and government sectors within China.
Aili is a leading figure in the promotion of Chinese Traditional Medicine (TCM) as an alternative to western Pharmaceutical based options. Aili is also one of very few Chinese people recognised by Royal Society of Medicine.